FMQSX
Price
$15.56
Change
+$0.07 (+0.45%)
Updated
Oct 20 closing price
Net Assets
2.7B
RIRGX
Price
$79.67
Change
+$0.42 (+0.53%)
Updated
Oct 20 closing price
Net Assets
119.59B
Interact to see
Advertisement

FMQSX vs RIRGX

Header iconFMQSX vs RIRGX Comparison
Open Charts FMQSX vs RIRGXBanner chart's image
Franklin Mutual Quest R
Price$15.56
Change+$0.07 (+0.45%)
VolumeN/A
Net Assets2.7B
American Funds Capital Income Bldr R6
Price$79.67
Change+$0.42 (+0.53%)
VolumeN/A
Net Assets119.59B
FMQSX vs RIRGX Comparison Chart in %
View a ticker or compare two or three
VS
FMQSX vs. RIRGX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMQSX is a Hold and RIRGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIRGX has more cash in the bank: 120B vs. FMQSX (2.7B). FMQSX pays higher dividends than RIRGX: FMQSX (4.20) vs RIRGX (3.21). FMQSX was incepted earlier than RIRGX: FMQSX (16 years) vs RIRGX (16 years). FMQSX (1.27) is less costly to investors than RIRGX (0.27). RIRGX is a more actively managed with annual turnover of: 56.00 vs. FMQSX (48.47). RIRGX has a lower initial minimum investment than FMQSX: RIRGX (250) vs FMQSX (1000). RIRGX annual gain was more profitable for investors over the last year : 11.13 vs. FMQSX (10.50). RIRGX return over 5 years is better than : 54.58 vs. FMQSX (49.63).
FMQSXRIRGXFMQSX / RIRGX
Total Expense Ratio1.270.27470%
Annual Report Gross Expense Ratio1.270.27470%
Fund Existence16 years16 years-
Gain YTD13.60517.38278%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.7B120B2%
Annual Yield % from dividends4.203.21131%
Returns for 1 year10.5011.1394%
Returns for 3 years40.9049.0183%
Returns for 5 years49.6354.5891%
Returns for 10 years35.8463.1557%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATAI6.450.97
+17.70%
ATAI Life Sciences NV
HSIC62.980.95
+1.53%
Henry Schein
CPIX3.44-0.01
-0.29%
Cumberland Pharmaceuticals
BPYPM15.36-0.16
-1.04%
Brookfield Property Partners LP
CTNM11.70-0.76
-6.10%
Contineum Therapeutics